Household contact management for rifampicin-resistant tuberculosis

Lancet Glob Health. 2022 Oct;10(10):e1387. doi: 10.1016/S2214-109X(22)00362-X.

Authors

Anja Reuter¹, Ivy Apolisi¹, Johnny Daniels¹, Jennifer Furin², Helen Cox³

Affiliations

¹ Médecins Sans Frontiàres, Khayelitsha, South Africa.
² Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: jenniferfurin@gmail.com.
³ Division of Medical Microbiology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

PMID: 36113520
DOI: 10.1016/S2214-109X(22)00362-X

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / therapeutic use
Humans
Rifampin* / therapeutic use
Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

Antitubercular Agents
Rifampin